Both in Pharmaceuticals
Equillium vs Polaryx Therapeutics
Over the past year EQ returned +7.3% and PLYX returned −94.1%; their daily moves had a correlation of 0.07.
EQ +7.3% PLYX −94.1%Growth of $1, one year, split-adjusted
| Metric | EQ | PLYX |
|---|---|---|
| Price | $1.62 | $2.07 |
| Market cap | $102.7M | $103.2M |
| Today | −3.57% | +1.47% |
| 1 month | −32.2% | +0.5% |
| 6 months | −7.4% | −68.7% |
| Year to date | +4.5% | — |
| 1 year | +8.0% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $57.2M | $11.5M |
| Dividend yield | — | — |
| Volatility (60d) | 80.6% | 76.3% |
| Short % of float | 12.3% | 1.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).